日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CRAF dimerization with ARAF regulates KRAS-driven tumor growth

CRAF 与 ARAF 二聚化调节 KRAS 驱动的肿瘤生长

Avinashnarayan Venkatanarayan, Jason Liang, Ivana Yen, Frances Shanahan, Benjamin Haley, Lilian Phu, Erik Verschueren, Trent B Hinkle, David Kan, Ehud Segal, Jason E Long, Tony Lima, Nicholas P D Liau, Jawahar Sudhamsu, Jason Li, Christiaan Klijn, Robert Piskol, Melissa R Junttila, Andrey S Shaw, Ma

Hunchback prevents notch-induced apoptosis in the serotonergic lineage of Drosophila Melanogaster

Hunchback 可阻止果蝇血清素能谱系中 Notch 诱导的细胞凋亡

Pérez, Ernesto; Venkatanarayan, Avinashnarayan; Lundell, Martha J

NRG1 is a critical regulator of differentiation in TP63-driven squamous cell carcinoma

NRG1是TP63驱动的鳞状细胞癌分化过程中的关键调节因子。

Ganapati V Hegde ,Cecile de la Cruz ,Jennifer M Giltnane ,Lisa Crocker ,Avinashnarayan Venkatanarayan ,Gabriele Schaefer ,Debra Dunlap ,Joerg D Hoeck ,Robert Piskol ,Florian Gnad ,Zora Modrusan ,Frederic J de Sauvage ,Christian W Siebel ,Erica L Jackson

Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumors.

激活 p53 家族成员 TAp63:一种针对 p53 改变肿瘤的新型治疗策略

Gunaratne Preethi H, Pan Yinghong, Rao Abhi K, Lin Chunru, Hernandez-Herrera Anadulce, Liang Ke, Rait Antonina S, Venkatanarayan Avinashnarayan, Benham Ashley L, Rubab Farwah, Kim Sang Soo, Rajapakshe Kimal, Chan Clara K, Mangala Lingegowda S, Lopez-Berestein Gabriel, Sood Anil K, Rowat Amy C, Coarfa Cristian, Pirollo Kathleen F, Flores Elsa R, Chang Esther H

Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant Tumors

RAS-GTP 的药理诱导使 KRAS 突变肿瘤对 RAF 抑制剂产生敏感性

Ivana Yen, Frances Shanahan, Mark Merchant, Christine Orr, Thomas Hunsaker, Matthew Durk, Hank La, Xiaolin Zhang, Scott E Martin, Eva Lin, John Chan, Yihong Yu, Dhara Amin, Richard M Neve, Amy Gustafson, Avinashnarayan Venkatanarayan, Scott A Foster, Joachim Rudolph, Christiaan Klijn, Shiva Malek

ΔNp63/DGCR8-Dependent MicroRNAs Mediate Therapeutic Efficacy of HDAC Inhibitors in Cancer

ΔNp63/DGCR8 依赖性 MicroRNA 介导 HDAC 抑制剂对癌症的治疗效果

Marco Napoli, Avinashnarayan Venkatanarayan, Payal Raulji, Brooke A Meyers, William Norton, Lingegowda S Mangala, Anil K Sood, Cristian Rodriguez-Aguayo, Gabriel Lopez-Berestein, Harina Vin, Madeleine Duvic, Michael B Tetzlaff, Jonathan L Curry, Alain H Rook, Hussein A Abbas, Cristian Coarfa, Preeth

Novel therapeutic interventions for p53-altered tumors through manipulation of its family members, p63 and p73

通过调控其家族成员 p63 和 p73,开发针对 p53 改变肿瘤的新型治疗干预措施

Venkatanarayan, Avinashnarayan; Raulji, Payal; Norton, William; Flores, Elsa R

IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo

IAPP 驱动的代谢重编程诱导体内 p53 缺陷肿瘤消退

Avinashnarayan Venkatanarayan, Payal Raulji, William Norton, Deepavali Chakravarti, Cristian Coarfa, Xiaohua Su, Santosh K Sandur, Marc S Ramirez, Jaehuk Lee, Charles V Kingsley, Eliot F Sananikone, Kimal Rajapakshe, Katherine Naff, Jan Parker-Thornburg, James A Bankson, Kenneth Y Tsai, Preethi H Gu

Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma

HDAC 和 KDM1A 联合抑制对胶质母细胞瘤的临床前活性

Melissa M Singh, Blake Johnson, Avinashnarayan Venkatarayan, Elsa R Flores, Jianping Zhang, Xiaoping Su, Michelle Barton, Frederick Lang, Joya Chandra

Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancers

3q26.2位点hsa-miR-569拷贝数增加导致TP53INP1缺失和上皮癌侵袭性增强。

Chaluvally-Raghavan, Pradeep; Zhang, Fan; Pradeep, Sunila; Hamilton, Mark P; Zhao, Xi; Rupaimoole, Rajesha; Moss, Tyler; Lu, Yiling; Yu, Shuangxing; Pecot, Chad V; Aure, Miriam R; Peuget, Sylvain; Rodriguez-Aguayo, Cristian; Han, Hee-Dong; Zhang, Dong; Venkatanarayan, Avinashnarayan; Krohn, Marit; Kristensen, Vessela N; Gagea, Mihai; Ram, Prahlad; Liu, Wenbin; Lopez-Berestein, Gabriel; Lorenzi, Philip L; Børresen-Dale, Anne-Lise; Chin, Koei; Gray, Joe; Dusetti, Nelson J; McGuire, Sean E; Flores, Elsa R; Sood, Anil K; Mills, Gordon B